Wave Life Sciences Ltd.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation Singapore
Business Address 7 STRAITS VIEW, SINGAPORE, U0, 018936
Mailing Address 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
Phone 617-949-2900
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2025
-$57.51M
Net Income
$638.50M
Total Assets
$134.82M
Total Liabilities
$518.36M
Stockholders' Equity
$602.07M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 30, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 27, 2026 | View on SEC |
| 10-K Annual financial report | February 26, 2026 | View on SEC |
| 8-K Current report of material events | February 26, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 12, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
Annual Reports
10-K February 26, 2026
- Lead program WVE-006 for AATD is in Phase 1b/2a clinical trial, with initial data anticipated.
- Strengthened collaborations with GSK and Takeda provide significant research funding, potential milestone payments, and external validation of technology.
Insider Trading
STRONG BUY 12 insiders
47 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.